Volume 68, Issue 5, Pages (May 2018)

Slides:

Advertisements

Similar presentations

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep

Advertisements

Depression, anemia and health-related quality of life in chronic hepatitis C Amy A. Dan, Lisa M. Martin, Cathy Crone, Janus P. Ong, Denise W. Farmer, Thomas.

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.

Volume 61, Issue 2, Pages (August 2014)

Volume 63, Issue 1, Pages (July 2015)

Volume 46, Issue 3, Pages (March 2007)

The impact of hepatitis E in the liver transplant setting

Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen

Volume 65, Issue 1, Pages S82-S94 (October 2016)

Inflammasomes in liver diseases

Volume 61, Issue 4, Pages (October 2014)

Volume 50, Issue 4, Pages (April 2009)

MELD: the holy grail of organ allocation?

Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review Christian Thoma, Christopher P. Day, Michael.

Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou

Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar

Volume 51, Issue 6, Pages (December 2009)

The impact of hepatitis E in the liver transplant setting

Matthew T. Kitson, Stuart K. Roberts Journal of Hepatology

NS5A inhibitors in the treatment of hepatitis C

Volume 65, Issue 1, Pages S82-S94 (October 2016)

Immigration and viral hepatitis

Virological tools to diagnose and monitor hepatitis C virus infection

The association of chronic kidney disease and dialysis treatment with foot ulceration and major amputation Jeroen Otte, MD, MSc, Jaap J. van Netten,

Ype P. de Jong, Charles M. Rice, Alexander Ploss Journal of Hepatology

Living donor liver transplantation: is the hype over?

Volume 69, Issue 2, Pages (August 2018)

Volume 44, Pages S19-S24 (January 2006)

Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection Anaïs Vallet-Pichard,

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

Volume 65, Issue 4, Pages (October 2016)

Volume 68, Issue 1, Pages (January 2018)

Hepatitis C core protein – The “core” of immune deception?

Volume 61, Issue 1, Pages S108-S119 (November 2014)

The association of chronic kidney disease and dialysis treatment with foot ulceration and major amputation Jeroen Otte, MD, MSc, Jaap J. van Netten,

Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel

Volume 70, Issue 1, Pages (January 2019)

Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study Gyuri Kim, Suk-Yong Jang, Chung.

Volume 61, Issue 1, Pages S69-S78 (November 2014)

Volume 62, Issue 3, Pages (March 2015)

Management of cirrhosis due to chronic hepatitis C

Genomic risk of hepatitis C-related hepatocellular carcinoma

Darius Moradpour, Arash Grakoui, Michael P. Manns

Autophagy in the liver Journal of Hepatology

Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore

EASL Clinical Practice Guidelines: Wilson’s disease

Volume 61, Issue 1, Pages S45-S57 (November 2014)

Hashem B. El-Serag, Thomas P

Economics of chronic hepatitis B and hepatitis C

A.H. Gifford Journal of Cystic Fibrosis

The changing role of beta-blocker therapy in patients with cirrhosis

Volume 65, Issue 2, Pages (August 2016)

EASL Clinical Practice Guidelines on hepatitis E virus infection

Volume 50, Issue 4, Pages (April 2009)

Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong

Immigration and viral hepatitis

HCV targeting of patients with cirrhosis

Volume 63, Issue 1, Pages (July 2015)

Volume 51, Issue 2, Pages (August 2009)

Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences Zobair M. Younossi, Aybike Birerdinc,

Chronic hepatitis B in children and adolescents

Hepatitis C treatment in patients with kidney disease

Michael J. Germain, MD, Sara N. Davison, MD, Alvin H. Moss, MD

Liver transplantation in children

Pathogenesis of cholestatic hepatitis C

American Journal of Kidney Diseases

Chimeric mouse model of hepatitis B virus infection

Volume 54, Issue 6, Pages (June 2011)

MELD: the holy grail of organ allocation?

Reversion of disease manifestations after HCV eradication

Presentation transcript:

Volume 68, Issue 5, Pages 904-911 (May 2018) Higher risk of renal disease in chronic hepatitis C patients: Antiviral therapy survival benefit in patients on hemodialysis Jonas Söderholm, Charlotta Millbourn, Katharina Büsch, Jan Kövamees, Robert Schvarcz, Karin Lindahl, Annette Bruchfeld Journal of Hepatology Volume 68, Issue 5, Pages 904-911 (May 2018) DOI: 10.1016/j.jhep.2017.12.003 Copyright © 2017 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2018 68, 904-911DOI: (10. 1016/j. jhep. 2017. 12 Copyright © 2017 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Kaplan-Meier survival curve for CHC patients on HD. Patients grouped by (A) HCV treatment or (B) kidney transplantation. Kaplan-Meier survival curve for HD patients grouped by HCV treatment depending on if the patient (C) had not or (D) had received kidney transplantation. Time started at HD initiation. Log-rank test was used. CHC, chronic hepatitis C; HCV, hepatitis C virus; HD, hemodialysis. Journal of Hepatology 2018 68, 904-911DOI: (10.1016/j.jhep.2017.12.003) Copyright © 2017 European Association for the Study of the Liver Terms and Conditions